Premium
Comparative analysis of two coxsackievirus B3 strains: Putative influence of virus‐receptor interactions on pathogenesis
Author(s) -
Selinka H.C.,
Wolde A.,
Pasch A.,
Klingel K.,
Schnorr J.J.,
Küpper J.H.,
Lindberg A.M.,
Kandolf R.
Publication year - 2002
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.2211
Subject(s) - biology , coxsackievirus , virology , virus , receptor , cytopathic effect , pathogenesis , decay accelerating factor , microbiology and biotechnology , antibody , enterovirus , immunology , genetics , complement system
Strain‐specific differences in the interaction of coxsackievirus B3 (CVB3) with the coxsackievirus‐adenovirus receptor (CAR) and the decay‐accelerating factor (DAF) co‐receptor proteins were investigated using a non‐haemagglutinating (CVB3) and a haemagglutinating (CVB3‐HA) strain of CVB3. A panel of receptor‐transfected hamster CHO cells, expressing either CAR (CHOCAR cells), DAF (CHODAF cells), or both receptor proteins (CHODC cells) were used to study the interplay of CAR and DAF receptor molecules with regard to binding and infection with CVB3 and CVB3‐HA. Despite clear differences in their binding phenotypes, both virus strains were found to primarily depend on the CAR receptor protein for initialization of productive infections. Cytopathic effects induced by CVB3‐HA were influenced by co‐expression of DAF receptor proteins. The cardiotropic potential of both virus strains was investigated in A.BY/SnJ mice. Despite comparable virus replication of both CVB3 strains in individual myocytes, the number of infected heart muscle cells was significantly lower in CVB3‐HA infected mice. Infections of pancreata correlated with myocardial infections. Together these data suggest that even small differences in virus‐receptor interactions, influencing virus binding and virus spread, may have an impact on the pathogenesis of CVB‐induced diseases. J. Med. Virol. 67:224–233, 2002. © 2002 Wiley‐Liss, Inc.